MedaRed


Public lists: Pharma Startups (6570)

MedaRed is developing an antibody that has shown promise in preclinical studies as a potential treatment to protect the nervous system from MS damage.

MedaRed is developing an antibody that has shown promise in preclinical studies as a potential treatment to protect the nervous system from MS damage.

Company (Alive / Active)

Phone:

Fax:

1650 Owens Street
Room 259
San Francisco, 94158
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MedaRed $6.8M May 17, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MedaRed Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)